MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,588,000
EPS
-$0.38
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
1,201,000
3,543,723
4,726,130.5*
2,196,828
General and administrative
1,499,000
1,431,482
2,766,269*
1,056,560
Total operating expenses
2,700,000
4,975,205
7,492,399.5
3,253,388
Loss from operations
-2,700,000
-4,975,205
-7,492,399.5*
-3,253,388
Other expense
-
-
640*
-
Interest income
116,000
44,270
38,417*
37,023
Interest expense
4,000
6,111
5,778.5*
2,116
Total other income (expense)
112,000
38,159
31,998.5*
34,907
Net loss
-2,588,000
-4,937,046
-7,460,401
-3,218,481
Basic EPS
-0.38
-7.3
-16.827
-5.76
Diluted EPS
-0.38
-7.3
-16.827
-5.76
Basic Average Shares
6,838,205
676,172
443,369*
558,868
Diluted Average Shares
6,838,205
676,172
443,369*
558,868
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$116,000
(200.45%↑ Y/Y)
Net loss
-$2,588,000
(-8.97%↓ Y/Y)
Total other income
(expense)
$112,000
(225.35%↑ Y/Y)
Interest expense
$4,000
(-4.42%↓ Y/Y)
Loss from operations
-$2,700,000
(-12.06%↓ Y/Y)
Total operating
expenses
$2,700,000
(12.06%↑ Y/Y)
General and
administrative
$1,499,000
(20.66%↑ Y/Y)
Research and development
$1,201,000
(2.91%↑ Y/Y)
Buy us a coffee
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)